Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to compare Utidelone with Docetaxel in patients with
locally advanced or metastatic non-small cell lung cancer previously failed
platinum-containing chemotherapy regimens. This phase III, open-label, randomized controlled
trial aims to evaluate and compare the efficacy and safety of Utidelone and Docetaxel in the
aforementioned lung cancers.